[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Nicholas Meyer [@Nichola68773113](/creator/twitter/Nichola68773113) on x XX followers Created: 2025-07-18 13:11:24 UTC $nvct dual news next week!!!! 1: NXP-800 1b data. Very much expect >15% ORR (3x effective as SOC) and move to phase X (approval after 2a which is a confirmatory of 1v 2: NXP-900 start 1b for >200k patient TAM in single and combo therapy for NSCLC. Analogous to $smmt XXX engagements  **Related Topics** [combo](/topic/combo) [soc](/topic/soc) [$nvct](/topic/$nvct) [$smmt](/topic/$smmt) [Post Link](https://x.com/Nichola68773113/status/1946196104485237027)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Nicholas Meyer @Nichola68773113 on x XX followers
Created: 2025-07-18 13:11:24 UTC
$nvct dual news next week!!!! 1: NXP-800 1b data. Very much expect >15% ORR (3x effective as SOC) and move to phase X (approval after 2a which is a confirmatory of 1v
2: NXP-900 start 1b for >200k patient TAM in single and combo therapy for NSCLC. Analogous to $smmt
XXX engagements
/post/tweet::1946196104485237027